U067 “Bread n’ Butter with a Side of Nutella”: Short n’ Sweet, High-Yield Updates on Management of Bread n’ Butter Dermatologic Diseases
DESCRIPTION
In this fast-paced, high-impact session, our expert team delivers “Short n’ Sweet” updates on the bread-and-butter dermatologic conditions you encounter every day. Each update is loaded with practical, evidence-based insights you can start using in clinic tomorrow — sure to impress colleagues, trainees, and patients alike. Whether you’re in training, private practice, or academic medicine, these clinical pearls will sharpen your decision-making and elevate your everyday care. No time to keep up with the latest derm evidence? Let us do the heavy lifting for you.
LEARNING OBJECTIVES
Summarize real-world database and comparative effectiveness research on current treatments for common dermatologic diseases and specific disease phenotypes
Summarize key updates on new, existing, and upcoming treatments for common dermatologic diseases — delivering practical insights that matter to trainees, community clinicians, and academic dermatologists alike.
Diagnose and treat common dermatologic diseases using cutting-edge advances— with real-world applications for trainees, practicing dermatologists, and academic experts alike.
SCHEDULE
8:00 AM
Pearls from the Plains: High-Yield and Practical Insights in Oncodermatology
Jesse Philip Hirner, MD, FAAD
8:10 AM
Hair Today, More Hair Tomorrow: Cutting-Edge Updates in Hair Loss
Sarah Lonowski, MD, MBA, FAAD
8:20 AM
Psoriasis: What’s New, What Matters
David Rosmarin, MD, FAAD
8:30 AM
Beyond the Scratch: Breakthroughs in Itch and Emerging Therapies
Daniel Charles Butler, MD, FAAD
8:40 AM
The Cutting Edge: High Yield Updates in Treatment of Skin Cancer
Vanessa Voss, MD, FAAD
8:50 AM
AI in Dermatology: Innovations, Insights, and Emerging Applications
Yevgeniy Semenov, MD, MS, FAAD
DIRECTOR
Erin Barrett, MD, FAAD
SPEAKERS
Daniel Charles Butler, MD, FAAD
Jesse Philip Hirner, MD, FAAD
Sarah Lonowski, MD, MBA, FAAD
David Rosmarin, MD, FAAD
Yevgeniy Semenov, MD, MS, FAAD
Vanessa Voss, MD, FAAD
DISCLOSURES
Erin Barrett, MD, FAAD
Eli Lilly – Investigator(No Compensation Received); Guidepoint Global, LLC – Other(Fees); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(No Compensation Received); Sanofi Speaker Programs – Speaker/Faculty Education(Honoraria);
Daniel Charles Butler, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Galderma – Advisory Board(Fees); Leo Pharma Inc – Advisory Board(Fees); Novartis – Advisory Board(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Speaker(Honoraria);
Jesse Philip Hirner, MD, FAAD
No financial relationships exist with ineligible companies.
Sarah Lonowski, MD, MBA, FAAD
AstraZeneca – Investigator(Grants/Research Funding); Bristol Myers Squibb – Other(Other Financial Benefit); Eli Lilly – Investigator(Grants/Research Funding); Priovant Therapeutics – Advisory Board(No Compensation Received); Veradermics – Consultant (1099 relationship)(Fees);
David Rosmarin, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Abcuro, Inc. – Consultant(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); AltruBio Inc. – Consultant(Honoraria); Amgen – Speaker(Honoraria); Arena Pharmaceuticals – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Celgene Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Concert Pharmaceuticals – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); CSL Behring – Consultant(Honoraria); Dermavant Sciences – Advisory Board(Honoraria), Speaker(Honoraria); Dermira – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding), Other(Other Financial Benefit), Speaker(Honoraria); Janssen Biotech – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Merck & Co., Inc – Investigator(Grants/Research Funding); Nektar Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); RAPT Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Recludix Pharma – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Revolo Therapeutics – Consultant(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); UCB – Advisory Board(Honoraria); Viela Bio – Advisory Board(Honoraria); Zura Bio – Consultant (1099 relationship)(Honoraria);
Yevgeniy Semenov, MD, MS, FAAD
Bristol Myers Squibb – Consultant (1099 relationship)(Honoraria); Journal of the American Academy of Dermatology – Other(Salary); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria);
Vanessa Voss, MD, FAAD
Castle Biosciences – Advisory Board(Honoraria), Investigator(Grants/Research Funding);